SCHEMBL931348

SCHEMBL931348

O=C1CNCCN1CCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.49
MEN1 O00255 2/20 0.46
GAA P10253 2/20 0.46
HTT P42858 2/20 0.46
KMT2A Q03164 2/20 0.46
USP2 O75604 1/20 0.46
MAPT P10636 1/20 0.46
HSD17B10 Q99714 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MCHR1 Q99705 1/20 0.46
ACHE P22303 1/20 0.44
SLC6A3 Q01959 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
DAO P14920 1/20 0.43
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986031 0.91 SIGMAR1 (0.58) SIGMAR1SLC6A3DAOTSHRSMN1; SMN2
SCHEMBL28547803 0.91 MCHR1 (0.47) SIGMAR1MEN1GAAHTTKMT2A
SCHEMBL92331 0.85 L3MBTL1 (0.56) SIGMAR1MEN1GAAKMT2AMAPT
SCHEMBL11335574 0.84 ALDH1A1 (0.50) MEN1GAAKMT2AMAPTMCHR1
SCHEMBL8399418 0.84 SLC6A3 (0.52) SIGMAR1HSD17B10SLC6A3DAO
Hydrochloric Acid SCHEMBL4768580 0.83 L3MBTL1 (0.54) SIGMAR1MEN1GAAKMT2AMAPT
Bromide SCHEMBL28426487 0.83 L3MBTL1 (0.54) SIGMAR1MEN1GAAKMT2AMAPT
SCHEMBL18076547 0.82 SIGMAR1 (0.51) SIGMAR1SLC6A3TSHRSMN1; SMN2GSK3A
SCHEMBL27363764 0.81 PKM (0.56) SIGMAR1MEN1GAAHTTKMT2A
SCHEMBL14893955 0.80 KCNJ1 (0.64) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3257852-A1 PREPARATION METHOD FOR PRAZIQUANTEL AND INTERMEDIATE COMPOUNDS THEREOF Zhejiang Hisun Pharmaceutical Co., Ltd. (CN) 2017-12-20 EP disclosed
WO-2017158147-A1 PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE SAVIRA PHARMACEUTICALS GMBH (AT) 2017-09-21 WO disclosed
WO-2011003007-A1 AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF ALBANY MOLECULAR RESEARCH, INC. (US) 2011-01-06 WO disclosed
US-5998415-A Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors MERCK SHARP & DOHME LTD. (GB) 1999-12-07 US disclosed
EP-0815105-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS HOECHST MARION ROUSSEL, INC. (US) 1998-01-07 EP disclosed
WO-1997016446-A1 BICYCLIC HETEROARYL-ALKYLENE-(HOMO)PIPERAZINONES AND THIONE ANALOGUES THEREOF, THEIR PREPARATION AND THEIR USE AS SELECTIVE AGONISTS OF 5-HT1-LIKE RECEPTORS MERCK SHARP & DOHME LIMITED (GB) 1997-05-09 WO disclosed
WO-1996028441-A1 HETEROCYCLIC SUBSTITUTED PIPERAZINONE DERIVATIVES AS TACHYKININ RECEPTOR ANTAGONISTS HOECHST MARION ROUSSEL, INC. (US) 1996-09-19 WO disclosed